Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Addiction (Abingdon, England)|November 4, 2022
The opioid epidemic: A worldwide exploratory study using the WHO pharmacovigilance databaseMarion Robert, Emilie Jouanjus, Charles Khouri, et al.
Fundamental & Clinical Pharmacology|July 14, 2018
Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?Gaétan Gentile, Maeva Jego, Michel Spadari, et al.
Clinical Drug Investigation|June 15, 2016
Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance DatabaseJean-Baptiste Bossard, Camille Ponté, Julie Dupouy, et al.
Frontiers in Psychiatry|February 22, 2021
Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of VigilanceMarine Tambon, Camille Ponté, Emilie Jouanjus, et al.
Clinical Drug Investigation|July 27, 2018
Identification of Somatic Disorders Related to Psychoactive Drug Use from an Inpatient Database in a French University HospitalMargaux Lafaurie, Liselotte Pochard, Clémence Lotiron, et al.
Clinical Drug Investigation|July 7, 2021
Establishing and Evaluating a Study Questionnaire on Knowledge and Attitudes of Healthcare Professionals Towards Recreational and Medical Cannabis Across EuropeEmilie Jouanjus, Carla Sans-Pola, Beatrice Mainoli, et al.
Pharmacoepidemiology and Drug Safety|February 24, 2021
Evolution of medication consumption in a working environment in France: Results of the four waves of the "Drugs and Work" study (1986-2016)Fabrice Herin, Jerome Othenin, Emilie Jouanjus, et al.
Therapie|July 31, 2016
Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse historyDamien Driot, Bruno Chicoulaa, Emilie Jouanjus, et al.
Heart (British Cardiac Society)|June 17, 2025
Cardiovascular risk associated with the use of cannabis and cannabinoids: a systematic review and meta-analysisWilhelm Storck, Meyer Elbaz, Cécile Vindis, et al.
Therapie|July 7, 2019
A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in FranceMarine Auffret, Benjamin Rolland, Hélène Béhal, et al.
Pageof 5